Resource
Extended Release Naltrexone (Vivitrol®)
The U.S. Food and Drug Administration (FDA) has approved three medications for use in treating opioid dependence: methadone, buprenorphine, and naltrexone. Extended release naltrexone, brand name Vivitrol®, is a once-monthly injection intended to help prevent relapse to opioid use. Read this fact sheet for more information on naltrexone.
Drug Replacement and Maintenance Therapy
Fact Sheet
The U.S. Food and Drug Administration (FDA) has approved three medications for use in treating opioid dependence: methadone, buprenorphine, and naltrexone. Extended release naltrexone, brand name Vivitrol®, is a once-monthly injection intended to help prevent relapse to opioid use. Read this fact sheet for more information on naltrexone.
Drug Replacement and Maintenance Therapy
Fact Sheet